Additionally, EGFR, an RTK, was shown to activate the PI3K/AKT/mTOR pathway, and it is overexpressed in HNSCC, as corroborated by the UALCAN analysis (Figure 5) [240]. This evidence concerns the gene AKT1 and head and neck squamous cell carcinoma.